{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T15:30:40Z","timestamp":1767108640790,"version":"build-2065373602"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.transci.2021.103341","type":"journal-article","created":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T02:30:26Z","timestamp":1639103426000},"page":"103341","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["High titers of anti-A1 and anti-B antibodies among Peruvian group O platelet donors"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8259-8760","authenticated-orcid":false,"given":"Gissel","family":"Aguilar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna","family":"Gonzales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5455-2423","authenticated-orcid":false,"given":"Steev","family":"Loyola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8242-3098","authenticated-orcid":false,"given":"Jos\u00e9 A.","family":"Paredes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2021.103341_bib0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2147\/JBM.S234374","article-title":"Platelet Transfusion: And Update on Challenges and Outcomes","volume":"11","author":"Solves Alcaina","year":"2020","journal-title":"J Blood Med"},{"key":"10.1016\/j.transci.2021.103341_bib0010","first-page":"334","article-title":"\u00bf Es posible la transfusi\u00f3n de plaquetas no isogrupo ABO?","volume":"31","author":"Mart\u00ednez","year":"2015","journal-title":"Rev Cuba Hematol Inmunol y Hemoter"},{"key":"10.1016\/j.transci.2021.103341_bib0015","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1182\/asheducation-2007.1.172","article-title":"Evidence-based platelet transfusion guidelines","author":"Slichter","year":"2007","journal-title":"Hematol Am Soc Hematol Educ Progr"},{"key":"10.1016\/j.transci.2021.103341_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2019.100593","article-title":"Review of current transfusion therapy and blood banking practices","volume":"38","author":"Storch","year":"2019","journal-title":"Blood Rev"},{"key":"10.1016\/j.transci.2021.103341_bib0025","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1159\/000268058","article-title":"Platelet concentrates","volume":"36","year":"2009","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.transci.2021.103341_bib0030","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/tme.12687","article-title":"Comparison of ABO antibody titration, IgG subclasses and qualitative haemolysin test to reduce the risk of passive haemolysis associated with platelet transfusion","volume":"30","author":"Bastos","year":"2020","journal-title":"Transfus Med"},{"issue":"Suppl 1","key":"10.1016\/j.transci.2021.103341_bib0035","first-page":"114S","article-title":"Risks of hemolysis due to anti-A and anti-B caused by the transfusion of blood or blood components containing ABO-incompatible plasma","volume":"53","author":"Bers\u00e9us","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2021.103341_bib0040","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1111\/trf.15240","article-title":"Fatal acute hemolytic transfusion reaction due to anti-B from a platelet apheresis unit stored in platelet additive solution","volume":"59","author":"Balbuena-Merle","year":"2019","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2021.103341_bib0045","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.12659\/AJCR.915521","article-title":"Fletcher CH. Acute intravascular hemolysis following an ABO non-identical platelet transfusion: a case report and literature review","volume":"20","author":"Moinuddin","year":"2019","journal-title":"Am J Case Rep"},{"key":"10.1016\/j.transci.2021.103341_bib0050","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4103\/ajts.AJTS_36_17","article-title":"Incompatible crossmatch: first sign of a hemolytic transfusion reaction due to out-of-group platelet transfusion","volume":"13","author":"Basu","year":"2019","journal-title":"Asian J Transfus Sci"},{"key":"10.1016\/j.transci.2021.103341_bib0055","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1046\/j.1537-2995.2001.41060790.x","article-title":"Association of ABO\u2010mismatched platelet transfusions with morbidity and mortality in cardiac surgery","volume":"41","author":"Blumberg","year":"2001","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2021.103341_bib0060","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1537-2995.2004.03290.x","article-title":"Significant numbers of apheresis-derived group O platelet units have \u201chigh-titer\u201d anti-A\/A,B: implications for transfusion policy","volume":"44","author":"Josephson","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2021.103341_bib0065","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1537-2995.2010.02759.x","article-title":"A practical strategy to reduce the risk of passive hemolysis by screening plateletpheresis donors for high-titer ABO antibodies","volume":"51","author":"Quillen","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2021.103341_bib0070","first-page":"132","article-title":"Italian Society of Transfusion M, et al. Recommendations for the transfusion of plasma and platelets","volume":"7","author":"Liumbruno","year":"2009","journal-title":"Blood Transfus"},{"key":"10.1016\/j.transci.2021.103341_bib0075","article-title":"Comparison of abo antibody levels in apheresis platelets suspended in platelet additive solution and plasma","author":"Kc","year":"2020","journal-title":"Hematol Transfus Cell Ther"},{"key":"10.1016\/j.transci.2021.103341_bib0080","first-page":"83","article-title":"ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies","volume":"42","author":"Josephson","year":"2010","journal-title":"Transfus Apher Sci Off J World Apher Assoc Off J Eur Soc Haemapheresis"},{"key":"10.1016\/j.transci.2021.103341_bib0085","series-title":"Frecuencia de grupos sangu\u00edneos ABO y factor Rh, en la Comunidad Nativa De Supayaku. Cajamarca\u2013Per\u00fa. Rev cient\u00edfica pakamuros","first-page":"7","author":"Corro","year":"2016"},{"key":"10.1016\/j.transci.2021.103341_bib0090","series-title":"Gu\u00eda t\u00e9cnica para la selecci\u00f3n del donante de sangre humana y hemocomponentes","first-page":"53","author":"Ministerio de Salud del Per\u00fa","year":"2018"},{"key":"10.1016\/j.transci.2021.103341_bib0095","first-page":"90","article-title":"Sistema de gesti\u00f3n de la calidad del Programa Nacional de Hemoterapia y Bancos de Sangre (PRONAHEBAS)","author":"Ministerio de Salud del Per\u00fa","year":"2004","journal-title":"Gesti\u00f3n de Procesos."},{"key":"10.1016\/j.transci.2021.103341_bib0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21307\/immunohematology-2019-167","article-title":"Performance of an automated solid-phase red cell adherence system compared with that of a manual gel microcolumn assay for the identification of antibodies eluted from red blood cells","volume":"27","author":"Finck","year":"2011","journal-title":"Immunohematology"},{"key":"10.1016\/j.transci.2021.103341_bib0105","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.transci.2012.03.018","article-title":"Solid Phase Red Cell Adherence Assay: a tubeless method for pretransfusion testing and other applications in transfusion science","volume":"46","author":"Ching","year":"2012","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2021.103341_bib0110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.21307\/immunohematology-2021-006","article-title":"Comparative evaluation of the conventional tube test and column agglutination technology for ABO antibody titration in healthy individuals: a report from India","volume":"37","author":"Datta","year":"2021","journal-title":"Immunohematology"},{"key":"10.1016\/j.transci.2021.103341_bib0115","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/vox.12713","article-title":"Comparison of the tube test and column agglutination techniques for anti-A\/-B antibody titration in healthy individuals","volume":"113","author":"Matsuura","year":"2018","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2021.103341_bib0120","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.bjhh.2016.05.007","article-title":"Dangerous universal donors: the reality of the hemocentro in Belo Horizonte, minas gerais","volume":"38","author":"Godin","year":"2016","journal-title":"Rev Bras Hematol Hemoter"},{"key":"10.1016\/j.transci.2021.103341_bib0125","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1001\/jama.1987.03390130095036","article-title":"Consensus conference. Platelet transfusion therapy","volume":"257","year":"1987","journal-title":"JAMA"},{"key":"10.1016\/j.transci.2021.103341_bib0130","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4103\/0973-6247.200765","article-title":"Antibody titers in Group O platelet donors","volume":"11","author":"Tendulkar","year":"2017","journal-title":"Asian J Transfus Sci"},{"key":"10.1016\/j.transci.2021.103341_bib0135","series-title":"Transfusion therapy: blood and blood products. Roberts Hedges\u2019 clin. Proced. Emerg. Med. Acute care","first-page":"1500","author":"Roberts","year":"2018"},{"key":"10.1016\/j.transci.2021.103341_bib0140","first-page":"17","article-title":"Evaluation of anti-A and anti-B alloisogglutinin titer in group O plateletpheresis donors","volume":"1","author":"Kavallierou","year":"2015","journal-title":"Hematol Transfus Int J"},{"key":"10.1016\/j.transci.2021.103341_bib0145","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1111\/j.1537-2995.2009.02208.x","article-title":"Probiotic-associated high-titer anti-B in a group A platelet donor as a cause of severe hemolytic transfusion reactions","volume":"49","author":"Daniel-Johnson","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2021.103341_bib0150","doi-asserted-by":"crossref","first-page":"108","DOI":"10.21307\/immunohematology-2020-024","article-title":"Quality improvement with platelet additive solution for safer out-of-group platelet transfusions","volume":"35","author":"Tynuv","year":"2019","journal-title":"Immunohematology"},{"key":"10.1016\/j.transci.2021.103341_bib0155","doi-asserted-by":"crossref","first-page":"259","DOI":"10.5581\/1516-8484.20110073","article-title":"Titers of ABO antibodies in group O blood donors","volume":"33","author":"de Franca","year":"2011","journal-title":"Rev Bras Hematol Hemoter"},{"key":"10.1016\/j.transci.2021.103341_bib0160","first-page":"230","article-title":"Prevalencia de disponentes de plaquetas con t\u00edtulos altos de anti-A y anti-B","volume":"60","author":"Med\u00e9cigo","year":"2013","journal-title":"Rev Mex Patol Cl\u00ednica y Med Lab"},{"key":"10.1016\/j.transci.2021.103341_bib0165","doi-asserted-by":"crossref","first-page":"e1413","DOI":"10.1002\/wsbm.1413","article-title":"Human microbiota, blood group antigens, and disease","volume":"10","author":"Ewald","year":"2018","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"key":"10.1016\/j.transci.2021.103341_bib0170","doi-asserted-by":"crossref","DOI":"10.1038\/s41435-020-0105-9","article-title":"Emergence and significance of carbohydrate-specific antibodies","author":"Kappler","year":"2020","journal-title":"Genes Immun"},{"key":"10.1016\/j.transci.2021.103341_bib0175","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1111\/trf.13374","article-title":"How do I implement an automated screen for high-titer ABO antibody as an inventory management tool for ABO plasma-incompatible platelets?","volume":"55","author":"Fontaine","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2021.103341_bib0180","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1111\/trf.15273","article-title":"Immunoglobulin M anti-A and anti-B titers in South Texas group O D+ male donors","volume":"59","author":"Beddard","year":"2019","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2021.103341_bib0185","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/jcla.21499","article-title":"The characteristics of ABO antibodies in group O Thai blood donors","volume":"26","author":"Khampanon","year":"2012","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.transci.2021.103341_bib0190","doi-asserted-by":"crossref","first-page":"131","DOI":"10.5858\/arpa.2015-0351-OA","article-title":"Impact of uniform methods on interlaboratory antibody titration variability: antibody titration and uniform methods","volume":"141","author":"Bachegowda","year":"2017","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.transci.2021.103341_bib0195","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1111\/j.1537-2995.2012.03574.x","article-title":"ABO antibody titers are not predictive of hemolytic reactions due to plasma-incompatible platelet transfusions","volume":"52","author":"Karafin","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2021.103341_bib0200","doi-asserted-by":"crossref","first-page":"909","DOI":"10.5858\/2007-131-909-TOPCAP","article-title":"Transfusion of platelets containing ABO-incompatible plasma: a survey of 3156 North American laboratories","volume":"131","author":"Fung","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.transci.2021.103341_bib0205","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4103\/0973-6247.162684","article-title":"Current trends in platelet transfusions practice: the role of ABO-RhD and human leukocyte antigen incompatibility","volume":"9","author":"Valsami","year":"2015","journal-title":"Asian J Transfus Sci"},{"key":"10.1016\/j.transci.2021.103341_bib0210","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/trf.13077","article-title":"Easier said than done: ABO compatibility and D matching in apheresis platelet transfusions","volume":"55","author":"Dunbar","year":"2015","journal-title":"Transfusion"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050221003499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050221003499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:53:58Z","timestamp":1761468838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050221003499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1473050221003499"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2021.103341","relation":{},"ISSN":["1473-0502"],"issn-type":[{"type":"print","value":"1473-0502"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High titers of anti-A1 and anti-B antibodies among Peruvian group O platelet donors","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2021.103341","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103341"}}